Accelmed Partners
TOP 50 PE Winner
2022
Firm Inception: 2009
Number of Active Portfolio Investments: 10
Number of Realized Investments: 2
Investment Range: $50M
Current Fund: Fund II
Current Fund Size: $400M
Transactions completed since October 2020, including acquisitions, add-ons, and divestments:
Medminder, Neuropace, TearLab.
Leadership:
Dr. Uri Geiger - Founder & Managing Partner
Lior Shav - General Partner
Eric Tansky - General Partner
Steven Rubin - General Partner
Team Members: 12
Primary Address: 848 Brickell Ave, #901, Miami, FL 33131
Website: www.accelmed.com
Phone Number: 305-854-6815
Which best describes the firm?: Traditional | LP Funded
Industry focus: Healthcare & Technology
Attributes: Firm Growth, Unique Firm Strategy, Operations Management, Deal Execution, Portfolio Excellence, Team Building, Performance, Private Equity Innovation, Other Attributes that are Award Worthy
Firm Growth - Firm is growing with 4 new members joining in 2H 2021 (Eric Tansky (GP), Steve Rubin (GP), Katherine Relle (VP).
Unique Firm Strategy - Accelmed operates in a niche PE sector requiring expertise in healthcare, technology, health tech, medical tech regulation and more; Accelmed is appropriately staffed with SMEs for each of these sectors/specialties to appropriately diligence investment opportunities and offer top of the line operational support to portfolio companies.
Operations Strategy - Accelmed works closely with peer Board members and Management Teams to support portfolio companies using proprietary tools to do so.
Deal Execution & Portfolio Excellence - Accelmed has a track record of success. Specific portfolio information can be found here: https://accelmed.com/portfolio
Team Building - Accelmed values culture and advocates diversity of thought through the due diligence process as well as post-closing. Accelmed advocates for diverse board compositions. (e.g., Katherine Relle recently joined the Board of MedMinder). The team hosts quarterly team building offsites where a range of topics are discussed, including industry trends around creating a strong culture, DEI, and other related topics.
Performance - See portfolio: https://accelmed.com/portfolio
Private Equity Innovation - Accelmed works in an innovative industry, supporting health tech private firms grow. Many of these companies are based on cutting edge technology that Accelmed is uniquely positioned to analyze.
Accelmed is a global firm, with team members in Miami, New York/New Jersey and Tel Aviv. These three hubs are centers for innovation, technology and deal flow and Accelmed is well positioned to capture synergies among all three locations.
Overview
Accelmed Partners is a lower middle-market private equity firm focused on acquiring and investing in mature, U.S. based, commercial-stage HealthTech companies. For more than a decade, we have leveraged our deep HealthTech industry experience, operational and financial expertise, and strong relationships to help management teams at companies across the medical device, tools, diagnostics, digital health and tech-enabled services sectors position their businesses for future growth and success. Our ideal partners share our values of integrity, transparency and tenacity, directed toward leveraging technology to improve patient outcomes, reduce costs and increase efficiency throughout the healthcare system. We currently manage over $630 million of equity capital and are actively investing out of our second private equity fund, Accelmed Partners II.
Our core strategy is to identify companies with the potential to be leaders in HealthTech and leverage decades of operational and financial expertise amongst our General Partners to develop detailed strategic plans and execute diligently over time. We often employ a buy-and-build strategy in which Accelmed partners with management of a commercial platform and leads evaluation and acquisition of innovative products and technologies to boost growth.
Why do prospects want to do business with the firm?
Deal flow in a unique and growing sector; deep industry expertise; global team with global experience; strong reputation and returns.
Why do intermediaries present opportunities and want to conduct transactions with the firm?
Deal flow in a unique and growing sector; deep industry expertise; global team with global experience; strong reputation and returns.
Accelmed Partners
HQ
848 Brickell Ave,
#901,
Miami, FL
33131
Call 305-854-6815 | Visit https://accelmed.com/about→